Stay updated on Grass Pollen Allergy Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Grass Pollen Allergy Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Grass Pollen Allergy Immunotherapy Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:19:44.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or modification in the study details related to grass allergen sublingual immunotherapy (SLIT) and dupilumab for tolerance induction in adults with moderate to severe seasonal allergic rhinitis.
    Difference
    0.1%
    Check dated 2024-06-06T14:41:02.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    41%
    Check dated 2024-05-22T21:22:11.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:39:16.000Z thumbnail image

Stay in the know with updates to Grass Pollen Allergy Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Grass Pollen Allergy Immunotherapy Clinical Trial page.